Lv3
220 积分 2022-09-19 加入
Novel epigenetic therapeutic strategies and targets in cancer
8个月前
已完结
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
8个月前
已完结
Efficacy of chemotherapy in epidermal growth factor receptor (EGFR) mutated metastatic pulmonary adenocarcinoma patients who had acquired resistance to first-line EGFR tyrosine kinase inhibitor (TKI)
8个月前
已完结
Overcoming therapy resistance in EGFR-mutant lung cancer
8个月前
已完结
Targeting the epigenetic regulation of antitumour immunity
8个月前
已完结
The regulatory effect of Angelicae Sinensis Radix on neuroendocrine-immune network and sphingolipid metabolism in CUMS-induced model of depression
9个月前
已完结
Translational evidence for the Inflammatory Response System (IRS)/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depression
9个月前
已完结
Targeting the epigenetic regulation of antitumour immunity
11个月前
已完结
The Crossroads of Cancer Epigenetics and Immune Checkpoint Therapy
11个月前
已完结
Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality
1年前
已完结
皖公网安备34019202002308
